Patents by Inventor Corinne Moulon

Corinne Moulon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of cancer therapy by inhibiting fusion polypeptides comprising fibroblast growth factor receptor 2 (FGFR2) and vinculin (VCL)
    Patent number: 10703798
    Abstract: Fusion polypeptides have an FGFR2 polypeptide and cDNAs encode such fusion polypeptides. Methods of diagnosing the presence of the fusion polypeptides or of a gene or RNA sequence coding therefore in a sample from a subject as well as methods of treatment of a tumor instructed by the latter diagnosis.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: July 7, 2020
    Assignee: DEBIOPHARM INTERNATIONAL SA
    Inventors: Hiroaki Tanaka, Corinne Moulon, Anne Vaslin Chessex, Jérôme Wojcik, Claudia Armenise
  • FGFR EXPRESSION AND SUSCEPTIBILITY TO AN FGFR INHIBITOR
    Publication number: 20180223371
    Abstract: A method of selecting a subject suffering from a cancer for a therapeutic regimen of administration of a pharmaceutical composition comprising an effective amount of an FGFR inhibitor is described, which method comprises (1) the taking of a tumor or liquid biopsy from the subject; (2) determination of the level of expression of any or all of FGFR1, FGFR2 and FGFR3, and (3) comparison of the determined level of expression of at least one of FGFR1, FGFR2 and FGFR3 with a pre-established threshold value, and declaring the subject eligible for the therapeutic regimen if the determined level exceeds the threshold value. The invention also relates to a method of personalized cancer therapy comprising selection of a subject by the above-described method and subjecting the subject to a therapeutic regimen that comprises administration of a pharmaceutical composition comprising an effective amount of an FGFR inhibitor.
    Type: Application
    Filed: July 21, 2016
    Publication date: August 9, 2018
    Applicant: DEBIOPHARM INTERNATIONAL SA
    Inventors: Anne VASLIN-CHESSEX, Corinne MOULON, Franck BRICHORY, Anna POKORSKA-BOCCI
  • FGFR FUSIONS
    Publication number: 20170107271
    Abstract: Fusion polypeptides have an FGFR2 polypeptide and cDNAs encode such fusion polypeptides. Methods of diagnosing the presence of the fusion polypeptides or of a gene or RNA sequence coding therefore in a sample from a subject as well as methods of treatment of a tumor instructed by the latter diagnosis.
    Type: Application
    Filed: March 31, 2015
    Publication date: April 20, 2017
    Applicant: DEBIOPHARM INTERNATIONAL SA
    Inventors: Hiroaki TANAKA, Corinne MOULON, Anne Vaslin CHESSEX, Jérôme WOJCIK, Claudia ARMENISE
  • Synthetic chemokines labeled at selected positions
    Publication number: 20040138422
    Abstract: Labeled synthetic chemokine molecules are provided which are characterized by improved biological activity and methods for their production and use in detection of chemokine receptors.
    Type: Application
    Filed: September 23, 2003
    Publication date: July 15, 2004
    Inventors: Stephane Demotz, Corinne Moulon, Christophe Reymond, Mario Roggero, Andrew Strong, Jean Vizzavona, Pascal Cousin
  • Pharmaceutical composition for preventing or treating a disease associated with an excess of IL-12-production
    Publication number: 20020119967
    Abstract: This invention relates to the use of a PDE4 inhibitor or a pharmacologically acceptable salt thereof for manufacturing a medicament for preventing or treating a disease associated with an excess in IL-12 production.
    Type: Application
    Filed: September 15, 2001
    Publication date: August 29, 2002
    Inventors: Corinne Moulon, Heleen Heystck